The report attempts to show why therapeutic success in the treatment of Hodgkin's disease levelled off at the start of the Eighties. The prospects of future treatment based on more accurate interpretation of clinical and histopathological data, further cytological and immunological research as well as improved therapeutic techniques more carefully adapted to the variety of prognoses are also discussed.
View Article and Find Full Text PDF